%0 Letter
%T [New drug arrival : Pembrolizumab as second-line treatment in MSI-H/dMMR endometrial, colorectal, gastric, intestinal and biliary cancers].
%A El-Ghazzi N
%A Rousseau B
%A Rodrigues M
%J Bull Cancer
%V 110
%N 1
%D 01 2023
%M 36357200
%F 1.318
%R 10.1016/j.bulcan.2022.10.003
%X